| 【Company Research】CR Beer (291 HK) – Profit alert in line with us; still our sector top buy |
| 【Company Research】Haidilao (6862 HK) – Reforms on track, but hindered by pandemic |
| 【Company Research】Shengyi Technology (600183 CH) – Weaker 4Q21 with limited pricing upside in 2022; D/G to HOLD |
| 【Company Research】I-Mab BioPharma (IMAB US) – A significantly undervalued biotech company with solid pipeline assets |
| 【Fixed Income Research】TBLAIJ – Loan conclusion should lead to positive rating action |
| 【Company Research】Suspension of Coverage |
| 【Company Research】Yili Industrial (600887 CH) – Promotional expense on Winter Olympics could weigh on 4Q results |
| 【Sector Research】China Software & IT Services – China cloud market to recover in 2022E |
| 【Company Research】Termination of Coverage |
| 【行业研究】中国汽车行业 – 分析师路演反馈：爱之深，忧之切？ |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
